Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The optimal combination therapy for the treatment of early rheumatoid arthritis.
De Cock D, Van der Elst K, Meyfroidt S, Verschueren P, Westhovens R. De Cock D, et al. Among authors: meyfroidt s. Expert Opin Pharmacother. 2015;16(11):1615-25. doi: 10.1517/14656566.2015.1056735. Epub 2015 Jun 10. Expert Opin Pharmacother. 2015. PMID: 26058860 Review.
Unraveling Patient-Preferred Health and Treatment Outcomes in Early Rheumatoid Arthritis: A Longitudinal Qualitative Study.
van der Elst K, Meyfroidt S, De Cock D, De Groef A, Binnard E, Moons P, Verschueren P, Westhovens R. van der Elst K, et al. Among authors: meyfroidt s. Arthritis Care Res (Hoboken). 2016 Sep;68(9):1278-87. doi: 10.1002/acr.22824. Epub 2016 Jul 29. Arthritis Care Res (Hoboken). 2016. PMID: 26713518 Free article.
A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders.
Meyfroidt S, Stevens J, De Lepeleire J, Westhovens R, De Cock D, Van der Elst K, Vanhaecht K, Verschueren P. Meyfroidt S, et al. Eur J Gen Pract. 2015;21(4):231-7. doi: 10.3109/13814788.2015.1084279. Epub 2015 Nov 19. Eur J Gen Pract. 2015. PMID: 26679974
A maximum difference scaling survey of barriers to intensive combination treatment strategies with glucocorticoids in early rheumatoid arthritis.
Meyfroidt S, Hulscher M, De Cock D, Van der Elst K, Joly J, Westhovens R, Verschueren P. Meyfroidt S, et al. Clin Rheumatol. 2015 May;34(5):861-9. doi: 10.1007/s10067-015-2876-3. Epub 2015 Feb 26. Clin Rheumatol. 2015. PMID: 25711874
Patient experiences with intensive combination-treatment strategies with glucocorticoids for early rheumatoid arthritis.
Meyfroidt S, Van der Elst K, De Cock D, Joly J, Westhovens R, Hulscher M, Verschueren P. Meyfroidt S, et al. Patient Educ Couns. 2015 Mar;98(3):384-90. doi: 10.1016/j.pec.2014.11.011. Epub 2014 Nov 20. Patient Educ Couns. 2015. PMID: 25483574
Effectiveness of methotrexate with step-down glucocorticoid remission induction (COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial.
Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R. Verschueren P, et al. Among authors: meyfroidt s. Ann Rheum Dis. 2017 Mar;76(3):511-520. doi: 10.1136/annrheumdis-2016-209212. Epub 2016 Jul 18. Ann Rheum Dis. 2017. PMID: 27432356 Clinical Trial.
Patients lacking classical poor prognostic markers might also benefit from a step-down glucocorticoid bridging scheme in early rheumatoid arthritis: week 16 results from the randomized multicenter CareRA trial.
Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Van der Elst K, Meyfroidt S, Westhovens R; CareRA study group. Verschueren P, et al. Among authors: meyfroidt s. Arthritis Res Ther. 2015 Apr 9;17(1):97. doi: 10.1186/s13075-015-0611-8. Arthritis Res Ther. 2015. PMID: 25889222 Free PMC article. Clinical Trial.
Are illness perception and coping style associated with the delay between symptom onset and the first general practitioner consultation in early rheumatoid arthritis management? An exploratory study within the CareRA trial.
Van der Elst K, De Cock D, Vecoven E, Arat S, Meyfroidt S, Joly J, Moons P, Verschueren P, Westhovens R, CareRA Study Group. Van der Elst K, et al. Among authors: meyfroidt s. Scand J Rheumatol. 2016;45(3):171-8. doi: 10.3109/03009742.2015.1074278. Epub 2015 Sep 23. Scand J Rheumatol. 2016. PMID: 26399601
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P, De Cock D, Corluy L, Joos R, Langenaken C, Taelman V, Raeman F, Ravelingien I, Vandevyvere K, Lenaerts J, Geens E, Geusens P, Vanhoof J, Durnez A, Remans J, Vander Cruyssen B, Van Essche E, Sileghem A, De Brabanter G, Joly J, Meyfroidt S, Van der Elst K, Westhovens R. Verschueren P, et al. Among authors: meyfroidt s. Ann Rheum Dis. 2015 Jan;74(1):27-34. doi: 10.1136/annrheumdis-2014-205489. Epub 2014 Oct 30. Ann Rheum Dis. 2015. PMID: 25359382 Clinical Trial.
Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis.
Meyfroidt S, van Hulst L, De Cock D, Van der Elst K, Joly J, Westhovens R, Hulscher M, Verschueren P. Meyfroidt S, et al. Scand J Rheumatol. 2014;43(4):265-72. doi: 10.3109/03009742.2013.863382. Epub 2014 Feb 24. Scand J Rheumatol. 2014. PMID: 24559216 Clinical Trial.
14 results
Jump to page
Feedback